Enhanced catecholaminergic and serotoninergic activity in rat brain from weaning to sexual maturity: Rationale for prophylactic (-)deprenyl (selegiline) medication

This publication has 16 references indexed in Scilit:

• Sexually low performing male rats die earlier than their high performing peers and (-)deprenyl treatment eliminates this difference
  Life Sciences, 1994
• Chronic treatment of (-)deprenyl prolongs the life span of male fischer 344 rats. Further evidence
  Life Sciences, 1993
• Apparent antioxidant effect of l-deprenyl on hydroxyl radical formation and nigral injury elicited by MPP+ in vivo
  European Journal of Pharmacology, 1993
• The Pharmacological Profile of (–)Deprenyl (Selegiline) and its Relevance for Humans: A Personal View
  Basic & Clinical Pharmacology & Toxicology, 1992
• (−)Deprenyl and (−)parafluorodeprenyl-treatment prevents age-related pigment changes in the substantia nigra. A TV-image analysis of neuromelanin
  Mechanisms of Ageing and Development, 1992
• Maintenance on l-deprenyl prolongs life in aged male rats
  Life Sciences, 1990
• Striatal dopamine, sexual activity and lifespan. Longevity of rats treated with (-) deprenyl
  Life Sciences, 1989
• The striatal dopamine dependency of life span in male rats. Longevity study with (−)deprenyl
  Mechanisms of Ageing and Development, 1988
• Pargyline and deprenyl prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in monkeys
  European Journal of Pharmacology, 1984
• The possible mechanisms of action of (-)deprenyl in Parkinson's disease
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1978